BD Intevia™ 2.25 mL Disposable Autoinjector - Designed for reliable subQ delivery of high viscosity drugs with one single configuration

BD Intevia™ 2.25 mL Disposable Autoinjector - Designed for reliable subQ delivery of high viscosity drugs with one single configuration
Product Description

BD Intevia™ Disposable Autoinjector is a two-step, push-on-skin autoinjector designed to deliver a broad range of viscosities for chronic disease therapy. It is available in both 1 mL and 2.25 mL formats.

BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.

https://drugdeliverysystems.bd.com/contact-us

BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

SAS BECTON DICKINSON FRANCE

  • FR
  • 2015
    On CPhI since
  • 2
    Certificates
  • 5000+
    Employees

SAS BECTON DICKINSON FRANCE

  • FR
  • 2015
    On CPhI since
  • 2
    Certificates
  • 5000+
    Employees

More Products from SAS BECTON DICKINSON FRANCE

  • BD Libertas™ Wearable Injector - Supporting subQ delivery of large volume complex biologics

    Product BD Libertas™ Wearable Injector - Supporting subQ delivery of large volume complex biologics

    BD Libertas™ Wearable Injector is an innovative, hands-free injection system designed to automatically deliver high volume and/or highly viscous biotech drugs subcutaneously. It delivers a wide range of therapeutic drugs to the subcutaneous tissue over a period of time, ranging from a few seconds to several minutes. In 2018, BD Libertas™ was awarded the prestigious Good Design Award and the iF Design Award in recognition of its design prioritizing safety, convenience and usability to deliver high value drug treatments in a non-clinical setting.

    BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.                                                                                                                                                                                                                                                                            
    https://drugdeliverysystems.bd.com/contact-us                                                                                                     

    BD, the BD Logo and BD Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.
  • BD Evolve™ On-body Injector - Enabling variable drug delivery regimens

    Product BD Evolve™ On-body Injector - Enabling variable drug delivery regimens

    BD Evolve™ On-body Injector is being developed for pharmaceutical companies who seek flexible delivery options, as well as opportunities for improving the patient experience and lowering the cost of care. It supports delivery of biologics with customizable and programmable subcutaneous administration. BD Evolve™ On-body Injector is designed as a flexible system capable of continuous, episodic, or delayed delivery across a range of volumes, for extended wear and injection durations. It is meant to be programmable, with connected capabilities, and to enable subcutaneous administration of up to 3 mL of medication with up to 3 days of wear, allowing for medication delivery in a non-clinical setting.      

    BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.                                                                                                     
                       
    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Evolve are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.
  • BD Intevia™ 1 mL Disposable Autoinjector - Designed for reliable system integration and high viscosity biologics

    Product BD Intevia™ 1 mL Disposable Autoinjector - Designed for reliable system integration and high viscosity biologics

    BD Intevia™ Disposable Autoinjector is a two-step, push-on-skin autoinjector designed to deliver a broad range of viscosities for chronic disease therapy. It is available in both 1 mL and 2.25 mL formats.

    BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.  
  • BD Physioject™ Disposable Autoinjector - Clinically proven integrated solution

    Product BD Physioject™ Disposable Autoinjector - Clinically proven integrated solution

    BD Physioject™ Disposable Autoinjector is designed to fully integrate with BD Neopak™ and BD Hypak™ for Biotech 1 mL long Glass Prefillable Syringes to ensure optimal system functionality. 

    BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Physioject are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • BD Vystra™ Disposable Pen - Confidence in dose delivery

    Product BD Vystra™ Disposable Pen - Confidence in dose delivery

    BD Vystra™ Disposable Pen is an intuitive, high-quality and customizable pen injector designed to support therapies that require frequent, low-volume injections or variable dosing.  

    BD partners with you to develop self-injection systems that enable drug administration across a range of volumes and viscosities, leveraging BD primary container technology and expertise with a focus on reaching the market faster.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Vystra are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • BD Neopak™ XtraFlow™ Glass Prefillable Syringe for Biotech - Enabling  the delivery of complex and viscous biologics

    Product BD Neopak™ XtraFlow™ Glass Prefillable Syringe for Biotech - Enabling the delivery of complex and viscous biologics

    Needle length and needle wall diameter are key parameters influencing injection force for a given injection time and solution viscosity. Reducing the injection force required to deliver solutions by manual injection is a parameter influencing patient preference, especially when high viscosities are injected. BD Medical - Pharmaceutical Systems is launching BD Neopak™ XtraFlow™ – a prefillable, glass-based syringe solution featuring an 8 mm needle with thinner wall cannula technology. This solution enables the transition from 12.7mm needle length towards shorter, 8mm needles and provides reduced pressure and enhances flow with thinner wall needle technology. BD Neopak™ XtraFlow™ PFS can provide an improved solution for subcutaneous drug delivery for both end-users and for pharmaceutical companies.   

    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.

    https://drugdeliverysystems.bd.com/contact-us                          

    BD, the BD Logo, Neopak and XtraFlow are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

                                                                                                                                                                              
  • BD Neopak™ XSi™ Glass Prefillable Syringe for Biotech - Addressing silicone-related concerns

    Product BD Neopak™ XSi™ Glass Prefillable Syringe for Biotech - Addressing silicone-related concerns

    BD Neopak™ XSi™ Glass Prefillable Syringe For Biotech combines BD Neopak™ Syringe with proprietary immobilized silicone coating, significantly reducing potential concerns associated with silicone without introducing new chemical substances.
    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Neopak and XSi are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

  • BD Neopak™ Glass Prefillable Syringe for Biotech - Turning expertise into solutions for biotech drugs

    Product BD Neopak™ Glass Prefillable Syringe for Biotech - Turning expertise into solutions for biotech drugs

    BD Neopak™ Glass Prefillable Syringe For Biotech features advanced technologies to meet the  highest expectations of leading biopharmaceutical companies. BD Neopak™ is available in both 1 mL and 2.25 mL formats.     

    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs. 

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Neopak are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • BD Hypak™ for Biotech Glass Prefillable Syringe - Covering your bases for biotech drugs

    Product BD Hypak™ for Biotech Glass Prefillable Syringe - Covering your bases for biotech drugs

    BD Hypak™ for Biotech is our versatile prefillable syringe delivery system that addresses key factors of compatibility with biopharmaceutical drugs.

    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hypak are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • BD UltraSafe Plus™ 2.25 mL Passive Needle Guard - Advancing needlestick safety solution for higher volume drugs

    Product BD UltraSafe Plus™ 2.25 mL Passive Needle Guard - Advancing needlestick safety solution for higher volume drugs

    BD UltraSafe Plus™ Passive Needle Guard for prefilled ISO standard 1 mL long and 2.25 mL glass syringes is designed to support viscous drug delivery with ergonomics and drug visibility. 

    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and UltraSafe Plus are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.  
  • BD UltraSafe Plus™ 1 mL  Passive Needle Guard - Advancing needlestick safety solutions

    Product BD UltraSafe Plus™ 1 mL Passive Needle Guard - Advancing needlestick safety solutions

    BD UltraSafe Plus™ Passive Needle Guard for prefilled ISO standard 1 mL long and 2.25 mL glass syringes is designed to support viscous drug delivery with ergonomics and drug visibility. 

    BD offers a broad portfolio of prefillable solutions specifically designed for biopharmaceuticals and chronic disease treatments. Our scientific expertise and breakthrough technologies backed by innovative global manufacturing capabilities enable these syringes while lowering total cost of ownership for your sensitive drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and UltraSafe Plus are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.  
  • BD Hylok™ Glass Prefillable Syringe For IV Injection - Make it a part of your drug development strategy

    Product BD Hylok™ Glass Prefillable Syringe For IV Injection - Make it a part of your drug development strategy

    BD Hylok™ Glass Prefillable Syringe for IV Injection is a new luer syringe for the administration of IV drugs. It offers customers the advantages of glass containers (e. g., medication stability) with a robust luer connection. BD Hylok™ is a ready-to-use glass solution, compatible with main IV connectors.

    https://drugdeliverysystems.bd.com/contact-us                         

    BD, the BD Logo and Hylok are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

SAS BECTON DICKINSON FRANCE resources

  • News BD Completes Study Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage

    Study reveals glass PFS can be stored at -20°C and -40°C without risk on PFS key product functions, establishing pathway to further assess the stability and performance of drug combination products with PFS in deep cold conditions.  
  • Whitepaper Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage

    While traditional vaccine formulations are commonly stored up to about 2°C-8°C, new vaccine formulations – including those for mRNA – require much colder storage for over a long period of time to ensure drug-product shelf-life and potency. Such low temperatures can induce changes in container dimensions, phase transition - liquid to solid and vice versa - and thermal shock. This could compromise the functional performance of the delivery system and Container Closure Integrity (CCI). BD began its investigation on the impact of deep cold storage on glass PFS as soon as information regarding the deep cold storage requirement for mRNA COVID-19 vaccines became available in 2020.

    BD study reveals that glass PFS can be stored at -20°C and -40°C without risk on PFS key product functions, establishing pathway to further assess the stability and performance of drug combination products with PFS in deep cold conditions.

    Discover more information in our press release...

  • News BD Intevia™ 2.25mL Disposable Autoinjector wins GOOD DESIGN® Award 2020

    Founded in 1950, GOOD DESIGN® is one of the world’s most prestigious, recognized, and oldest Design Awards program organized annually by The Chicago Athenaeum Museum of Architecture and Design in cooperation with the European Centre for Architecture, Art, Design and Urban Studies.
  • Whitepaper Selecting Drug Delivery Systems for Higher Doses, Higher Viscosities & Lower Risk

    The development of new parenteral biologics with high-volume, high-viscosity formulations (> 1 mL, >15 cP) is triggering the need for devices that can deliver these therapies with the ease, safety, and low injection time required for self-injection. As these formulations come to market, pharmaceutical and biotech companies must make critical device choices from an array of largely unproven options. The attachment discusses how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.  

    Discover the article published in Drug Development & Delivery in October 2021 (Vol 21 No 7)...
  • News BD unveils $1.2 billion investment in pre-fillable syringe manufacturing

    World’s largest syringe maker gears up for increased demand across all product classes amid expected COVID-19 vaccine roll out
  • Video BD Libertas™ Wearable Injector - Introductory overview

    BD Libertas™ Wearable Injector with Peel, Stick & Click™ feature is designed as a prefilled and preassembled solution to deliver 2 – 5 mL or 5 – 10 mL of viscous biologics into the subcutaneous tissue, at home or in clinical settings. Discover its main features and benefits!
                                                                                                                         
    https://drugdeliverysystems.bd.com/contact-us                                                                                                     
    BD, the BD Logo and BD Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.
  • News Robust by design – How BD is overcoming the biologics challenge in drug delivery

    This article explores how BD is dedicated to deliver best-in-class product performance and services by applying the latest advances in drug delivery technology.
  • Brochure BD SCF™ PremiumCoat™ 1 mlL Plunger Stopper - Supporting the delivery of biologics in 1 mlL prefilled systems

    Discover BD SCF™ PremiumCoat™ 1 mlL Plunger Stopper designed to serve the evolving needs of pharmaceutical organizations in the development of combination products for chronic diseases.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Intevia, Neopak, SCF, UltraSafe Plus, Visioguard and XSi are trademarks of Becton, Dickinson and Company or its affiliates.  All other trademarks are the property of their respective owners. © 2021 BD. All rights reserved.

  • News BD Launches innovative two-step disposable autoinjector

    New solution supports injection of different viscosities and volumes without the need for system customization.
  • Brochure BD Services & Solutions - Develop. De-risk. Deliver. [Brochure]

    Discover a comprehensive set of services and solutions designed to mitigate the risks associated with combination product development to help you achieve your goals. These services and solutions help you from development all the way through to launch, including container selection, combination product expertise and testing, regulatory and technical documentation support, analytical testing, world class lab capabilities, ongoing consultation, and more.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Video BD Services & Solutions - Develop. De-risk. Deliver. [Movie]

    Fabien Dubuc, Global Business Director, Combination Product Solutions and Services at BD, introduces a comprehensive set of services and solutions designed to mitigate the risks associated with combination product development to help you achieve your goals. These services and solutions help you from development all the way through to launch, including container selection, combination product expertise and testing, regulatory and technical documentation support, analytical testing, world class lab capabilities, ongoing consultation, and more.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Video BD PartnerPath™ Program

    Launching a combination product can be difficult and often comes with many challenges which can lead to development and launch delays. These delays equate to increased costs which can decrease the viability of market launches. The BD PartnerPath™ program was created for customers with new combination products in development, who value speed to market. It aims to help customers anticipate obstacles, mitigate risks and solve operational challenges in the early stages of drug development.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Partnerpath are trademarks of Becton, Dickinson and Company  or its affiliates © 2021 BD. All rights reserved.

  • Brochure BD PartnerPath™️ Program - Creating a clear pathway for the commercialization of your combination product

    Learn about BD’s answer to the many challenges faced by pharmaceutical companies having new combination products to launch: our BD PartnerPath™️ program created for customers who value speed to market.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and PartnerPath are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper The Future of Container-Level Traceability For Prefillable Syringes

    In this article, Sam Eubanks, Vice-President of Software Development, and Hervé Soukiassian, Associate Director, R&D Project Management, both of BD Medical -  Pharmaceutical Systems, discuss the BD traceability solution. This concept under development aims to deliver traceability at the unique container level from manufacture to the point of care.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Technical Data BD investing $1.2 billion into manufacturing of prefillable injection systems

    BD has plans to invest approximately $1.2 billion over a 4-year period. The investment will fund capacity expansion, new product innovations, manufacturing technology enhancements and business continuity improvements across its existing network, all designed to maximize supply and reduce risks for pharmaceutical companies that rely on ready-to-fill syringes for their injectable drugs - including complex biologics, vaccines and small molecules -. A new manufacturing facility in Europe is expected to be operational by the end of 2023.

    More information available in our datasheet.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 


  • Brochure BD Intevia™ 2.25mL Disposable Autoinjector wins Good Design Award

    Developed specifically to effectively and safely administer a variety of biologic medicines of differing viscosities up to 40cP, BD Intevia™ 2.25mL is a fully mechanical, high performance, 2-step push on skin disposable autoinjector. It is the only push on skin autoinjector that is designed with proprietary knowledge of primary container process controls, integrating key functionality to maximize product performance while also enabling delivery of different viscous drugs without customization.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

  • Brochure Autoinjector platform - Identifying new, enhanced device delivery solutions for chronic diseases

    Karima Yadi, Global Marketing Lead for the Autoinjector Platform - Lionel Maritan, R&D Associate Director (Drug Development & Delivery - January 14, 2020)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper BD Libertas™ effectively delivers dose volumes up to 5 mL subcutaneously

    New clinical trial data demonstrates the performance of BD Libertas™ Wearable Injector. A detailed analysis of the BD independently sponsored and conducted study has been published in Clinical and Translational Science (5 Dec 2020).

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

  • Brochure Frost & Sullivan’s Global 2020 Technology Innovation Award

    BD earns Frost & Sullivan’s Global 2020 Technology Innovation Award in the autoinjectable drug delivery device market.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper BD Hylok™ Glass Prefillable Syringe for IV applications

    Sophie Trémeau, Regulatory Affairs Specialist, Maxime Nicolas, R&D Engineer, and Myriam Leszczynski, R&D Project Manager, all of BD Medical – Pharmaceutical Systems, discuss BD Hylok™, a prefillable glass syringe for intravenous applications, including the rigorous testing BD Hylok™ has undergone and the regulatory support BD is able to provide to its pharmaceutical partners.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hylok are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Video BD Neopak™ Glass Prefillable Syringe - Turning expertise into advanced solutions for biotech

    Chronic diseases are on the rise worldwide. As a result, the pharma drug pipeline is rapidly changing, raising new challenges driven by more sensitive biologics, the need for home care self-injection solutions, and increasingly stringent quality and regulatory requirements. Our mission at BD Medical - Pharmaceutical Systems is to be your preferred strategic partner for high quality, innovative drug delivery solutions and services. We support the success of your combination products to make a real difference in patients’ lives. Drawing from 30 years of close collaboration with biopharma partners addressing the delivery challenges of complex biologics has led us to the launch of a tailored platform solution: BD Neopak™ Glass Prefillable Syringe.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Neopak are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved.
  • Brochure BD capabilities to support pharmaceutical industry’s COVID-19 response

    Discover how BD can accompany a development team working on drugs or vaccines against COVID-19, thanks to the specific expertise of its different businesses.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Whitepaper Robust by design - How BD is overcoming the biologics challenge in drug delivery

    BD Intevia™ 2.25 mL whitepaper
    Karima Yadi, Senior Manager, Global Portfolio Marketing & Lionel Maritan, R&D Associate Manager (European Pharmaceutical Review - August 25, 2020)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Intevia are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 

  • Whitepaper Addressing the evolving needs of variable drug delivery regimens

    Temitope Sodunke, PhD, Strategic Innovation Leader (On Drug Delivery - February 2020)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Evolve are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper BD completes clinical trial for BD Libertas™ Wearable Injector

    Press release - February 11, 2020

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper The changing drug delivery paradigm

    Beth DiLauri, Director, Strategic Marketing, Advanced Drug Delivery Solutions (On Drug Delivery - September 2019)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Neopak and Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper System integration

    Alice Maden, Associate Director, Regulatory Affairs & Lionel Maritan, Associate Director, Research & Development (On Drug Delivery - February 2019)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Physioject, Intevia, Neopak and Libertas are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper How shorter needles with thinner walls are set to improve the injection experience in chronic care

    Aurélie Pager, Clinical & Human Factors Program Leader - Brigitte Duinat, Senior Engineer - Barbara Alves, Regulatory Affairs Specialist (On Drug Delivery - May 2020)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Neopak and XtraFlow are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper 8 mm needle - Improving subcutaneous chronic drug delivery

    Aurelie Pager, Clinical & Human Factors Program Leader (On Drug Delivery - October 2019)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Neopak, Intevia and Physiolis are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper Hyaluronic acid dermal filler delivery in cosmetic applications

    Sagar Bejalwar, Global Marketing Manager (On Drug Delivery - February 2019)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hylok are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Brochure Administration challenges: Prefillable solutions in IV applications

    Discover BD offering to address the challenges of IV drug delivery and find the right primary container for your injectable in hospital care settings: BD Hylok™️ Glass Prefillable Syringe for IV injected drugs or BD Sterifill Advance™️ Polymer Prefillable Syringe!

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Hylok and Sterifill Advance are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Whitepaper Validation studies of BD Sterifill Advance™ Polymer Prefillable Syringe

    Cécile Halté, Senior Program Manager, Acute Care Segment (On Drug Delivery - August 2019)

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Sterifill Advance are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Brochure How BD offers support to COVID-19 drug and vaccine developers

    In this interview published in June 2020 in a special COVID-19 issue of Pharma’Post, Marie-Liesse Le Corfec, Head of Global Portfolio Marketing, presents the variety of means and capabilities deployed by BD to support Covid-19 drug and vaccine developers, help accelerate time-to-market and support global health.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Video BD Vystra™ Disposable Pen - Manufacturing

    BD Vystra™ Disposable Pen is an easy-to-use disposable pen injector for frequent, low-volume injections or variable dosing. The video details BD Vystra™ features and showcases the robust manufacturing process from component assembly through to final packaging for shipment.  

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Vystra are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Video Processing of BD Glass Prefillable Syringe Systems

    With more than 2.5 billion glass prefillable syringes processed and sold each year throughout the world, BD has developed and maintained state-of-the-art technology for the manufacture of  Sterile, Clean, ready to Fill syringes. The manufacturing process of BD Glass Prefillable Syringes is implemented in the same way in our plants in France, Hungary, the USA, Mexico and Japan. To meet worldwide demand, we implement worldwide technology processes and equipment through continual investment programs and multi-sourcing. Common Quality Assurance System and worldwide engineering organization guarantee a consistently high quality level, regardless of the manufacturing site. Final conditioning operations such as filling, stoppering, terminal sterilization, labelling and inspection, plunger rod placement and blister packaging are performed at pharmaceutical companies’ or contract-fillers’. 

    https://drugdeliverysystems.bd.com/contact-us
  • Brochure The Difference of One Drug Delivered - Portfolio Brochure

    Learn about our portfolio of solutions and services for a wide variety of therapeutic areas and settings: from home to hospital through outpatient clinic, and from vaccines to chronic disease treatments through small molecules and specialties, dermal fillers and contrast media… We provide unparalleled parenteral drug delivery systems, including glass and plastic syringe systems, self-injection devices, safety and shielding systems that set the standard.

    Discover why hundreds of pharmaceutical and biotechnology companies place their confidence in our high performing BD products and services...

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Brochure Brochure BD Prefillable Syringe Solutions

    Discover why hundreds of pharmaceutical and biotechnology companies place their confidence in our high performing BD products and services...

    https://drugdeliverysystems.bd.com/contact-us
  • Brochure Brochure BD Service Offering

    At BD, we have built our services and capabilities around a deep understanding of the drug development process and the key objectives at each stage. Knowledgeable and responsible, our team offers the many capabilities you need beyond taking your product to market. Each of our services is delivered intentionally and carefully to directly result in significant benefits for your product and company. 

    Discover why hundreds of pharmaceutical and biotechnology companies place their confidence in our high performing BD products and services...

    https://drugdeliverysystems.bd.com/contact-us
  • Brochure Brochure BD Technical Services

    Discover our capabilities and services, and partner with us to:Save time by leveraging our tried and tested expertise and methods Save money by eliminating the need to invest in costly machinery and other resources Gain confidence by working with an organization that has successfully helped launch hundreds of drug products  Free-up valuable internal resources that may be deployed to other critical activities.For more information, contact [email protected] or https://drugdeliverysystems.bd.com/contact-us


  • Brochure Brochure BD Hypak™ for Vaccines Glass Prefillable Syringe

    Our prefillable vaccine syringes provide multiple routes of administration options while helping enhance vaccination outcomes. 

    BD Hypak™ for Vaccines Glass Prefillable Syringe is our reliable glass prefillable syringe system specifically optimized for vaccinations. BD Hypak™ for Vaccines addresses customer needs of better processability of your syringe during filling and packaging operations.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hypak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 
  • Brochure Brochure BD Hylok™ Glass Prefillable Syringe For Intravenous Drugs - Make it a part of your drug launch strategy Glass Prefillable Syringe for Intravenous Drugs

    BD Hylok™ Glass Prefillable Syringe for IV Injection is a new luer syringe for the administration of IV drugs. It offers customers the advantages of glass containers (e. g., medication stability) with a robust luer connection. BD Hylok™ is a ready-to-use glass solution, compatible with main IV connectors. Discover how  BD Hylok™  can support your prefilled syringe “First-Mover” strategy.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hypak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 
  • Brochure Brochure BD Neopak™ Glass Prefillable Syringe For Biotech - Turning expertise into advanced solutions for biotech

    BD Neopak™ Glass Prefillable Syringe platform is built on years of BD’s unmatched experience partnering with leading biopharmaceutical companies to support drug development and launch. BD Neopak™ is conceived with a solution-finding mindset, allowing to tangibly meet your current and future needs for biotech drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Neopak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 

  • Brochure Brochure BD Neopak™ Glass Prefillable Syringe For Biotech (Innovators)

    Give tomorrow’s most demanding biotech drugs the strength of BD Neopak™ Prefillable Syringe technology!

    BD Neopak™ Glass Prefillable Syringe platform is built on years of BD’s unmatched experience partnering with leading biopharmaceutical companies to support drug development and launch. BD Neopak™ is conceived with a solution-finding mindset, allowing to tangibly meet your current and future needs for biotech drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Neopak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 

  • Brochure Brochure BD Neopak™ Glass Prefillable Syringe For Biotech (Life Cycle Management)

    Change to the reliability of BD Neopak™ platform to accompany your brand strategy!

    BD Neopak™ Glass Prefillable Syringe platform is built on years of BD’s unmatched experience partnering with leading biopharmaceutical companies to support drug development and launch. BD Neopak™ is conceived with a solution-finding mindset, allowing to tangibly meet your current and future needs for biotech drugs.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Neopak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved
  • Brochure Brochure BD Neopak™ Glass Prefillable Syringe For Biotech (Biosimilars)

    When time to market is critical, invest in the reliability of BD Neopak™ Glass Prefillable Syringe For Biotech!

    BD Neopak™ Glass Pre-fillable Syringe platform is built on years of BD’s unmatched experience partnering with leading biopharmaceutical companies to support drug development and launch. BD NeopakTM is conceived with a solution-finding mindset, allowing to tangibly meet your current and future needs for biotech drugs.

    https://drugdeliverysystems.bd.com/contact-us


    BD, the BD Logo and BD Neopak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 
  • Brochure Brochure BD Neopak™ XSi™ Glass Prefillable Syringe - Helping you address silicone-related concerns

    Concerned about silicone?

    Discover BD Neopak™ XSi™ Glass Prefillable Syringe with immobilized Silicone Coating to help you address silicone-related concerns!

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, BD Neopak and XSi are trademarks of Becton, Dickinson...
  • Brochure Brochure BD Hypak™ for Biotech Glass Prefillable Syringe

    Grounded on decades of BD Hypak™ experience, BD Hypak™ for Biotech has been developed to address the key compatibility challenges for biotech drugs and chronic treatments.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and Hypak are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 
  • Brochure Brochure BD Intevia™ 1 mL Disposable Autoinjector - A reliable, integrated system that helps push the boundaries of viscosity

    Discover BD Intevia™ 1 mL, a two-step, push-on-skin disposable autoinjector designed to deliver a broad range of viscosities for chronic disease therapy.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Intevia are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 

  • Brochure Brochure BD Vystra™ Disposable Pen - Expertise and efficiency combined

    Discover BD Vystra™ Disposable Pen, an intuitive, high-quality and customizable pen injector designed to support therapies that require frequent, low-volume injections or variable dosing.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Vystra are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 

  • Video Trends in Pharma Packaging, Administration & Drug Delivery Devices

    Faster, more cost-efficient hospital-based injectable drug delivery - How speed and convenience imperatives in the Covid-19 crisis have challenged the paradigms Overview and a discussion on the evolution of next-generation products Moderator: Yasemin Karanis, Consultant, European Thought Leadership, IQVIA Global Pharma: Trends in Drug Delivery and Formulations -Yasemin Karanis, Consultant, European Thought Leadership, IQVIA The increasing importance of connected devices and digitalization in post-pandemic R&D - Sai Shankar, Vice President, Global Digital Healthcare Systems, Aptar Pharma Illustration of implementing user experience key aspects and outlining holistic integrated combination products support - Mark Tunkel, Director of Business Development, Insight Innovation Center, Nemera Faster, more cost-efficient hospital-based injectable drug delivery - How speed and convenience imperatives in the Covid-19 crisis have challenged the paradigms - Sagar Bejalwar, Global Acute and Specialty Portfolio Leader, BD Medical – Pharmaceutical Systems Trends in sustainable packaging in the FMCG market - how this influences the Pharma business and ongoing developments - Armin Ullmann, Product Manager Sustainable Healthcare Laminates, Huhtamaki Flexible Packaging Sustainable packaging in Merck supply chain – ongoing and future developments - Corinne Ondo, Head of Sourcing Glass & Healthcare Innovation Group Procurement, Merck Healthcare This presentation was originally aired as part of the CPhI Festival of Pharma.
  • Video Vaccine Development Challenges: Speeding Up and Scaling Up

    The COVID-19 pandemic has lead governments, companies and research institutions to accelerate vaccine development efforts amid geopolitical crosscurrents. Despite an increased understanding of immune responses to infection, research is often hindered by a lack of knowledge of the immune responses explicitly required for protection, or by a lack of approved adjuvants and delivery systems to induce the needed answers. Licensing new vaccines also require a significant financial commitment which also represents a challenge. This webinar will discuss the hurdles that new vaccines must overcome to reduce morbidity and mortality, as well as some of the initiatives that are being attempted to accelerate and scale up the next generation of vaccine development for global disease prevention. This presentation was originally aired as part of the CPhI Festival of Pharma.
  • Video BD Hylok™️ for IV - Make it a part of your drug development strategy!

    Discover how BD addresses the challenges of IV drug delivery with BD Hylok™️ Glass Prefillable Syringe for IV applications. Learn about its features and performances!

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo and BD Hylok are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved. 
  • Brochure Innovating in the viscosity design space - New 2.25 mL autoinjector platform

    Extending its patient-centric BD Intevia™️ Disposable Autoinjector platform, BD builds on past successes while meeting the requirements of new, highly viscous, high-volume biologics for chronic diseases.

    https://drugdeliverysystems.bd.com/contact-us

    BD, the BD Logo, Intevia, Physioject, Neopak and XtraFlow are trademarks of Becton, Dickinson and Company or its affiliates © 2021 BD. All rights reserved. 
  • Brochure The search for drug dose optimization (The Pharma’ Post n° 5 - Feb. 2021)

    Interview of Marie-Liesse Le Corfec, Head of Global Portfolio Marketing at BD Medical - Pharmaceutical Systems, a leader in injectable drug delivery devices that is also in charge of the operational Task Force for coordinating the response and strategy with the pharmaceutical industry in the context of the health crisis.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Brochure The Difference of BD Solutions at Hospital, at Outpatient Clinic & at Home

    BD provides unparalleled parenteral drug delivery systems for a variety of therapeutic areas and settings, including glass & plastic syringes, advanced drug delivery solutions, safety & shielding systems that set the standard. Discover why hundreds of pharmaceutical and biotech companies place their confidence in BD high performing products and services.

    https://drugdeliverysystems.bd.com/contact-us

    BD and the BD Logo are trademarks of Becton, Dickinson and Company © 2021 BD. All rights reserved. 
  • Video Vial to Ready-To-Administer Need and BD Solution Offerings in Acute Care

    This webinar originally aired as part of CPhI Discover - 17-28 May 2021 Several factors motivate pharmaceutical companies and hospitals to use glass pre-fillable syringes (PFS) for Intravenous (IV) applications. By switching from vials and ampules to a glass PFS, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact ROI for hospital stakeholders. Moreover, data suggests that approximately 92% of hospital stakeholders are willing to use prefilled syringes for multiple drugs. For pharmaceutical companies, transitioning a fixed-dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules. This session will examine the benefits and challenges associated with glass formats and will explore BD’s glass pre-fillable syringe with connection performance verified for IV applications.
  • Video Patient-Centric Drug Delivery Solutions for Self-Administration

    This webinar originally aired as part of CPhI Discover - 17-28 May 2021 The need to reduce health care costs, improve outcomes, and increase access to remote care are intensifying the focus on patient care delivery in the home setting. As a result, pharma is seeking alternate delivery systems that can provide patient autonomy and mobility while delivering treatment outside of the clinic. Programmable, variable dose on-body injectors provide such options. This talk will highlight considerations for on-body injectors to promote drug delivery in non-clinical settings.
  • Video COVID-19: Delivering Vaccines to the Masses

    This webinar originally aired as part of CPhI Discover - 17-28 May 2021 While the initial challenge was in developing effective therapies against COVID-19, the next hurdles are manufacturing at scale, drug delivery solutions, cool chain and logistics. How is the industry responding? COVID Update: The 2021 Vaccine Line Up Facility challenges & production quality control Cold chain challenges Administration solutions-what are the options vs standard injections? Key supply chain challenges for vaccine products Creating sustainable and resilient distribution systems. Challenges in allocating and prioritizing vaccine supplies and distribution
  • Brochure BD Medication Delivery Solutions: Brochure BD MDS for Industry Partners - Enabling preparation and administration of injectable drugs worldwide

    From drug discovery, through manufacturing and quality controls, packaging and storage to preparation and administration, BD MDS delivers reliable and innovative solutions. Discover our offering for the industry!   

    Contact: BD Medication Delivery Solutions (Europe) - Route De Crassier, 17 - 1262 Eysins, Vaud - Switzerland - T: +41 21 556 30 00

    BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company © 2020 BD. All rights reserved

  • Brochure BD Medication Delivery Solutions: Brochure BD Eclipse™ - Designed and manufactured with nurses and patients in mind

    Discover BD Eclipse™, designed and manufactured with nurses and patients in mind! BD Eclipse™ needle is easy to use with minimal training, and supports streamlined and cost effective compliance for every practitioner, every day. BD Eclipse™ family of needles is a proven technology as it meets testing requirements for internationally recognized ISO 23908 standard for sharps injury protection with hypodermic injection needles. 

    Contact: BD Medication Delivery Solutions (Europe) - Route De Crassier, 17 - 1262 Eysins, Vaud - Switzerland - T: +41 21 556 30 00

    BD, the BD Logo and BD Eclipse are trademarks of Becton, Dickinson and Company © 2020 BD. All rights reserved
  • Brochure BD Medication Delivery Solutions: Brochure BD Injection Expertise - Pioneer and expert in the development of safety-engineered medical devices

    BD has developed an extensive line of safety-engineered devices, becoming a global leader in the field of healthcare workers safety. Discover our innovative portfolio of safety products protecting against needle stick injuries.

    Contact: BD Medication Delivery Solutions (Europe) - Route De Crassier, 17 - 1262 Eysins, Vaud - Switzerland - T: +41 21 556 30 00

    BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company © 2020 BD. All rights reserved

Recommended products